AB S.A. (WSE:ABE)

CTI BioPharma Revenue

AB S.A. had revenue of 3.15B PLN in the quarter ending March 31, 2025, a decrease of -1.79%. This brings the company's revenue in the last twelve months to 14.85B, down -20.45% year-over-year. In the fiscal year ending September 30, 2024, AB S.A. had annual revenue of 14.66B, down -4.70%.

• Revenue (ttm): 14.85B
• Revenue Growth: -20.45%
• P/S Ratio: 0.11
• Revenue / Employee: 11.99M
• Employees: 1,239
• Market Cap: 1.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	14.66B	-722.32M	-4.70%
Sep 30, 2023	15.38B	160.78M	1.06%
Jun 30, 2023	15.22B	960.42M	6.74%
Sep 30, 2022	14.26B	228.47M	1.63%
Jun 30, 2022	14.03B	956.52M	7.32%